γH2AX/53BP1 foci as a potential pre-treatment marker of HNSCC tumors radiosensitivity – preliminary methodological study and discussion

MLA

Olga Kopečná, et al. “ΓH2AX/53BP1 Foci as a Potential Pre-Treatment Marker of HNSCC Tumors Radiosensitivity – Preliminary Methodological Study and Discussion.” The European Physical Journal D, vol. 71, Sept. 2017. EBSCOhost, https://doi.org/10.1140/epjd/e2017-80073-2.

APA

Olga Kopečná, Alena Bačíková, Jaromír Gumulec, Daniel Depeš, Michal Masarik, Markéta Svobodová, Iva Falková, Martin Falk, Martina Raudenská, Zuzana Horáková, & Hana Binková. (2017). γH2AX/53BP1 foci as a potential pre-treatment marker of HNSCC tumors radiosensitivity – preliminary methodological study and discussion. The European Physical Journal D, 71. https://doi.org/10.1140/epjd/e2017-80073-2

Chicago

Olga Kopečná, Alena Bačíková, Jaromír Gumulec, Daniel Depeš, Michal Masarik, Markéta Svobodová, Iva Falková, et al. 2017. “ΓH2AX/53BP1 Foci as a Potential Pre-Treatment Marker of HNSCC Tumors Radiosensitivity – Preliminary Methodological Study and Discussion.” The European Physical Journal D 71 (September). doi:10.1140/epjd/e2017-80073-2.